|
1
|
Ito H, Matros E, Brooks DC, Osteen RT,
Zinner MJ, Swanson RS, Ashley SW and Whang EE: Treatment outcomes
associated with surgery for gallbladder cancer: a 20-year
experience. J Gastrointest Surg. 8:183–190. 2004.PubMed/NCBI
|
|
2
|
Randi G, Franceschi S and La Vecchia C:
Gallbladder cancer worldwide: geographical distribution and risk
factors. Int J Cancer. 118:1591–1602. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shukla PJ and Barreto SG: Gallbladder
cancer: we need to do better! Ann Surg Oncol. 16:2084–2085.
2009.
|
|
4
|
Gerner EW and Meyskens FL Jr: Polyamines
and cancer: old molecules, new understanding. Nat Rev Cancer.
4:781–792. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miao XP, Li JS, Li HY, Zeng SP, Zhao Y and
Zeng JZ: Expression of ornithine decarboxylase in precancerous and
cancerous gastric lesions. World J Gastroenterol. 13:2867–2871.
2007.PubMed/NCBI
|
|
6
|
Subhi AL, Tang B, Balsara BR, et al: Loss
of methylthioadenosine phosphorylase and elevated ornithine
decarboxylase is common in pancreatic cancer. Clin Cancer Res.
10:7290–7296. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Love RR, Astrow SH, Cheeks AM and
Havighurst TC: Ornithine decarboxylase (ODC) as a prognostic factor
in operable breast cancer. Breast Cancer Res Treat. 79:329–334.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Young L, Salomon R, Au W, Allan C, Russell
P and Dong Q: Ornithine decarboxylase (ODC) expression pattern in
human prostate tissues and ODC transgenic mice. J Histochem
Cytochem. 54:223–229. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Matsuba T, Yano M, Abiru N, Takino H,
Akazawa S, Nagataki S and Yasukawa K: Expression of recombinant
human glutamic acid decarboxylase (GAD) in myeloma cells and
enzyme-linked immunosorbent assay (ELISA) for autoantibodies to
GAD. J Biochem. 121:20–24. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pinal CS, Cortessis V and Tobin AJ:
Multiple elements regulate GAD65 transcription. Dev Neurosci.
19:465–475. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matuszek M, Jesipowicz M and Kleinrok Z:
GABA content and GAD activity in gastric cancer. Med Sci Monit.
7:377–381. 2001.PubMed/NCBI
|
|
12
|
Opolski A, Mazurkiewicz M, Wietrzyk J,
Kleinrok Z and Radzikowski C: The role of GABA-ergic system in
human mammary gland pathology and in growth of transplantable
murine mammary cancer. J Exp Clin Cancer Res. 19:383–390.
2000.PubMed/NCBI
|
|
13
|
Kleinrok Z, Matuszek M, Jesipowicz J,
Matuszek B, Opolski A and Radzikowski C: GABA content and GAD
activity in colon tumors taken from patients with colon cancer or
from xenografted human colon cancer cells growing as s. c tumors in
athymic nu/nu mice. J Physiol Pharmacol. 49:303–310.
1998.PubMed/NCBI
|
|
14
|
Kumar KN, Raja SB, Vidhya N and Devaraj
SN: Ellagic acid modulates antioxidant status, ornithine
decarboxylase expression, and aberrant crypt foci progression in
1,2-dimethylhydrazine-instigated colon preneoplastic lesions in
rats. J Agric Food Chem. 60:3665–3672. 2012. View Article : Google Scholar
|
|
15
|
Arisan ED, Obakan P, Coker A and
Palavan-Unsal N: Inhibition of ornithine decarboxylase alters the
roscovitine-induced mitochondrial-mediated apoptosis in MCF-7
breast cancer cells. Mol Med Rep. 5:1323–1329. 2012.
|
|
16
|
Manni A, Washington S, Griffith JW, et al:
Influence of polyamines on in vitro and in vivo features of
aggressive and metastatic behavior by human breast cancer cells.
Clin Exp Metastasis. 19:95–105. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kubo S, Tamori A, Tanaka H, et al:
Polyamine metabolism and recurrence after resection for
hepatocellular carcinoma. Hepatogastroenterology. 51:208–210.
2004.PubMed/NCBI
|
|
18
|
Smirnova OA, Isaguliants MG, Hyvonen MT,
et al: Chemically induced oxidative stress increases polyamine
levels by activating the transcription of ornithine decarboxylase
and spermidine/spermine-N(1)-acetyltransferase in human hepatoma
HUH7 cells. Biochimie. 94:1876–1883. 2012. View Article : Google Scholar
|
|
19
|
Barry EL, Mott LA, Sandler RS, Ahnen DJ
and Baron JA: Variants downstream of the ornithine decarboxylase
gene influence risk of colorectal adenoma and aspirin
chemoprevention. Cancer Prev Res (Philadelphia). 4:2072–2082. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wolf C, Brüss M, Hänisch B, Göthert M, von
Kügelgen I and Molderings GJ: Molecular basis for the
antiproliferative effect of agmatine in tumor cells of colonic,
hepatic, and neuronal origin. Mol Pharmacol. 71:276–283. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu X, Liu Z, Fang M, et al: CagA induces
ornithine decarboxylase upregulation via Src/MEK/ERK/c-Myc pathway:
implication for progression of gastric diseases Helicobacter
pylori. Exp Biol Med (Maywood). 237:435–441. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jaraj SJ, Augsten M, Häggarth L, Wester K,
Pontén F, Ostman A and Egevad L: GAD1 is a biomarker for benign and
malignant prostatic tissue. Scand J Urol Nephrol. 45:39–45. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takehara A, Hosokawa M, Eguchi H, Ohigashi
H, Ishikawa O, Nakamura Y and Nakagawa H: Gamma-aminobutyric acid
(GABA) stimulates pancreatic cancer growth through overexpressing
GABAA receptor pi subunit. Cancer Res. 67:9704–9712. 2007.
View Article : Google Scholar
|
|
24
|
Maemura K, Shiraishi N, Sakagami K, et al:
Proliferative effects of gamma-aminobutyric acid on the gastric
cancer cell line are associated with extracellular signal-regulated
kinase 1/2 activation. J Gastroenterol Hepatol. 24:688–696. 2009.
View Article : Google Scholar
|
|
25
|
Walls AB, Nilsen LH, Eyjolfsson EM, et al:
GAD65 is essential for synthesis of GABA destined for tonic
inhibition regulating epileptiform activity. J Neurochem.
115:1398–1408. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moon MS, Cho EW, Byun HS, Jung IL and Kim
IG: GAD 67KD antisense in colon cancer cells inhibits cell growth
and sensitizes to butyrate and pH reduction and
H2O2 and gamma-radiation. Arch Biochem
Biophys. 430:229–236. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mazurkiewicz M, Opolski A, Wietrzyk J,
Radzikowski C and Kleinrok Z: GABA level and GAD activity in human
and mouse normal and neoplastic mammary gland. J Exp Clin Cancer
Res. 18:247–253. 1999.PubMed/NCBI
|
